Phase diagram determination and process development for continuous antisolvent crystallizations
Mack, Corin and Hoffmann, Johannes and Sefcik, Jan and ter Horst, Joop H. (2022) Phase diagram determination and process development for continuous antisolvent crystallizations. Crystals, 12 (8). 1102. ISSN 2073-4352 (https://doi.org/10.3390/cryst12081102)
Preview |
Text.
Filename: Mack_etal_Crystals_2022_Phase_diagram_determination_and_process_development_for_continuous_antisolvent_crystallizations.pdf
Final Published Version License: Download (898kB)| Preview |
Abstract
The development of an antisolvent crystallization process requires the construction of an accurate phase diagram for this ternary system of compound, solvent and antisolvent, preferably as a function of temperature. This study gives an efficient methodology to systematically determine such antisolvent phase diagrams, exemplified with four model compounds: Sodium bromate, DL-Asparagine Monohydrate, Mefenamic acid and Lovastatin. Using clear point temperature measurements, single solvent and mixed solvent-antisolvent solubilities are obtained, showing strongly non-linear solubility dependencies as well as more complex solubility behaviour as a function of antisolvent fraction. A semi-empirical model equation is used to describe the phase diagram of the antisolvent crystallization system as a function of both temperature and antisolvent fraction. The phase diagram model then allows for the identification of condition ranges for optimal productivity, yield, and suspension density in continuous antisolvent crystallization processes.
ORCID iDs
Mack, Corin, Hoffmann, Johannes, Sefcik, Jan ORCID: https://orcid.org/0000-0002-7181-5122 and ter Horst, Joop H. ORCID: https://orcid.org/0000-0003-0118-2160;-
-
Item type: Article ID code: 81780 Dates: DateEvent6 August 2022Published6 August 2022Published Online22 July 2022AcceptedNotes: This article belongs to the Special Issue Recent Progress in Industrial Crystallization: https://www.mdpi.com/journal/crystals/special_issues/R_P_Industrial_Crystallization Subjects: Technology > Manufactures
Medicine > Pharmacy and materia medica
Medicine > Therapeutics. PharmacologyDepartment: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Technology and Innovation Centre > Continuous Manufacturing and Crystallisation (CMAC)
Technology and Innovation Centre > Bionanotechnology
Faculty of Engineering > Chemical and Process EngineeringDepositing user: Pure Administrator Date deposited: 09 Aug 2022 14:38 Last modified: 20 Nov 2024 01:23 URI: https://strathprints.strath.ac.uk/id/eprint/81780